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Bacterial  secondary  transporters  of  the  DctA  family  mediate  ion‐coupled  uptake  of  C4‐
dicarboxylates. Here we have expressed the DctA homologue from Bacillus subtilis  in  the 
Gram‐positive  bacterium  Lactococcus  lactis.  Transport  of  dicarboxylates  was  assayed  in 
vitro  in  isolated membrane vesicles. We determined the substrate specificity,  the type of 
cotransported  ions,  the  electrogenic  nature  of  transport,  and  the  pH  and  temperature 
dependence patterns. DctA was found to catalyze proton‐coupled symport of the four C4‐
dicarboxylates  from  the  Krebs  cycle  (succinate,  fumarate, malate  and  oxaloacetate),  but 
not  of  other  mono‐  and  dicarboxylates.  Because  (i)  succinate‐proton  symport  was 
electrogenic  (stimulated by an  inside‐negative membrane potential),  and  (ii)  the divalent 
anionic  form  of  succinate  was  recognized  by  DctA,  at  least  three  protons  must  be 






The DctA family  is one of several diverse  families of secondary transporters  that catalyze 
the  uptake  of  C4‐dicarboxylates  from  the  Krebs  cycle  in  bacteria  (54,  80).  In E.  coli  DctA 
mediates  the  uptake  of  succinate,  fumarate  and  malate  under  aerobic  conditions;  a 
genomic disruption of dctA in Escherichia coli prevents growth with malate or fumarate as 
the  sole  carbon  source,  and  the  mutant  grows  poorly  on  succinate  (19).  Similarly,  a 
knockout mutant of dctA in Bacillus subtilis cannot grow with succinate or fumarate as the 
sole  carbon  source  (5).  DctA  plays  a  major  role  in  the  symbiotic  relationship  between 
nitrogen  fixing  rhizobia  (124)  and  root‐nodule  forming  plants  (88,  101,  119).  Transport 




ketoglutarate,  oxaloacetate  and  glyoxylate  indicating  that  these  compounds  may  be 
substrates also (122). 
DctA transporters belong to a large family of secondary transporters (the DAACS family for 
Dicarboxylate/Amino  Acid:Cation  Symporter),  which  also  comprises  well‐characterised 
glutamate/aspartate  transporters,  and  neutral  amino  acid  transporters  (95,  102).  While 
DctA‐type  dicarboxylate  transporters  are  found  only  in  bacteria,  glutamate/aspartate 
transporters  of  the  DAACS  family  are  found  both  in  prokaryotes  (e.g.  GltT  in  Bacillus 
stearothermophilus, GltP in E. coli and GltPh in Pyrococcus horikoshii (31, 106, 121)) and in 
higher  eukarya,  where  they  play  a  pivotal  role  in  the  reuptake  of  the  excitatory 
neurotransmitter glutamate  from the synaptic cleft  (16). Neutral amino acid  transporters 
(alanine, serine, threonine) are found in mammalians (see, e.g., references (108) and (126)) 
as well as in bacteria (61).  
Secondary  transporters  of  the  DAACS  family  use  (electro)chemical  gradients  of  cations 
across  the  membrane  to  drive  transport.  The  type  of  cotransported  ions  varies  among 
family members: eukaryotic glutamate  transporters couple  the  transport of glutamate  to 
the symport of one proton and three sodium ions and the antiport of one potassium ion 
(68,  125).  Bacterial  and  archaeal  glutamate  transporters  utilize  either  sodium  ions  or 
protons for symport (9), and are independent of potassium ions (82, 90). The bacterial and 
mammalian neutral amino acid transporters are sodium ion coupled. Glutamate/aspartate 
transporters  and  bacterial  serine/threonine  transporters  (SstTs)  are  electrogenic,  but 
mammalian  neutral  amino  acid  transporters  are  obligate  electroneutral  amino  acid 
antiporters (126).  









of  the membrane  (14, 87). GltPh  forms a homotrimeric  complex,  in which each protomer 
functions independently of the other subunits (39, 41, 62, 63, 67). The fold and oligomeric 
state are likely to be conserved throughout the family. 
Whereas  the  transport  mechanisms  of  bacterial  glutamate  and  neutral  amino  acid 
transporters  of  the  DAACS  family  have  been  studied  extensively  in  vitro,  the  C4‐
dicarboxylate  transporters  of  the  DAACS  family  (DctA  proteins)  have  been  studied  using 
whole  cells  only.  To  fully  characterise  these  transporters,  in  vitro  activity  assays  using 
either membrane vesicles or proteoliposomes containing purified protein are necessary. In 
such assays the  internal and external buffer composition can be controlled, thus allowing 
manipulation  of  the  chemical  ion  gradients  and  the  electrical  potential  across  the 
membrane.  Here,  we  present  the  first  biochemical  characterisation  of  a  DctA  family 
member  in  membrane  vesicles.  We  have  studied  the  DctA  homologue  from  B.  subtilis, 
which  is  annotated  as  DctP  (5),  but  which  we  propose  to  rename  DctA  to  reflect  the 
homology with other DctA proteins. DctABs has 30‐32% sequence identity to the aspartate 
transporter GltPh  from P.  horikoshii  and human excitatory  amino  acid  transporter  (EAAT) 
family  members,  over  40%  sequence  identity  to  the  characterised  bacterial  glutamate 
transporters  from  E.  coli  and  B.  stearothermophilus,  and  41  and  56%  identity  to  DctA 














essentially  as  described  by Geertsma  and  Poolman  (35).  The  pRE‐Nlic  vector was  converted  into  a  plasmid  for 









was  induced  by  addition  of  nisin  (1:5000  v/v  dilution  of  the  culture  supernatant  of  stationary  phase  L.  lactis 





rotor).  Membrane  pellets  were  resuspended  in  20  mM  Tris‐HCl  (pH  8),  and  stored  at  ‐80°C.  The  protein 
concentration in the membranes was determined using Bradford reagent, with BSA as a standard. 
For protein purification (31), membrane vesicles were solubilized in buffer A (50 mM Tris‐HCl (pH 8.0), 300 mM 
NaCl),  containing  15  mM  imidazole  pH  8.0  and  1%  n‐dodecyl‐β‐D‐maltopyranoside  (DDM),  at  a  final  protein 






buffer A  supplemented with  500 mM  imidazole  pH 8.0  and  0.04% DDM.  The  second  elution  fraction  from  the 
affinity chromatography contained most of  the purified protein and was  loaded on a Superdex‐200 gelfiltration 
column, using 20 mM potassium phosphate pH 7.0, 150 mM NaCl, 0.04% DDM as eluens. 




L.  lactis  membrane  vesicles  were  mixed  in  a  1:10  (wt/wt)  ratio  of  protein  (from  the  membrane  vesicle 
preparation) to lipid (from liposomes) with liposomes made of E. coli polar lipids and egg PC (3:1 wt/wt), that had 
been  extruded  nine  times  through  a  400  nm  pore‐size  polycarbonate  filter,  using  a  miniextruder  (Hamilton, 
Bonaduz  CH).  The  mixture  was  frozen  in  liquid  nitrogen  and  thawed  three  times,  followed  by  centrifugation 
(267,000 rcf, 4°C, 20’, Beckman TLA 100.4 rotor). Fused membranes were then resuspended in the luminal buffer 






of  12.5 µg/µl.  In  transport  assays,  fused membrane  vesicles  were  diluted  100x  into  200 µl  of  external  buffer 
(specified in the results section), supplemented with [14C]succinate (3.1 µM, unless otherwise indicated) and 0.5 
µM valinomycin (if applicable, 3 mM stock solution in ethanol). All assays were performed at 25°C, except when 
otherwise  indicated,  and  internal  and  external  buffers were  iso‐osmotic.  Transport  reactions were  stopped  by 
addition  of  2 ml  of  ice‐cold  100 mM  LiCl,  followed  by  rapid  filtration  over  BA‐85  nitrocellulose  filters  and  an 
additional  wash  step  with  lithium  chloride.  Levels  of  radioactivity  were  determined  by  addition  of  2  ml  of 









Initially we  aimed  at  the  purification  of  DctABs  and  reconstitution  in  proteoliposomes.  A 





at  similar  volumes  (36,  120,  121),  indicating  that  DctABs  is  probably  also  a  homotrimer. 
However,  the  size  exclusion  chromatogram  showed  that  the  protein  was  prone  to 
aggregation  in  detergent  solution.  Static  light  scattering  analysis  (SEC‐MALLS)  of  DctABs 
indeed  showed  that  the  elution  peak  was  not  monodisperse,  but  the  results  were 
consistent  with  a  trimeric  oligomeric  state  of  the  protein  in  the  main  peak  (data  not 
shown). Varying the buffer composition (by the addition of glycerol or salt) or the pH (from 







a  12.5%  SDS‐PA  gel,  which  was  stained  with  coomassie  brilliant  blue.  Lane  1:  membrane  vesicles  (10  µg  of 
protein),  lane  2:  DDM‐soluble  fraction,  lane  3:  insoluble  fraction,  lane  4:  flow‐through  of  the  nickel‐sepharose 

















instability  of  the  protein  in  detergent  solution.  To  avoid  the  need  for  solubilization  of 
DctABs by detergents,  in vitro  transport assays using membrane vesicles prepared from L. 
lactis  cells  overexpressing  DctABs  were  attempted.  We  monitored  the  uptake  of 
radiolabeled  succinate  in  membrane  vesicles  in  the  presence  of  chemical  gradients  for 








or ThiT  (negative control;  triangles) were  loaded with 100 mM K‐HEPES  (pH 7.5). The vesicles were diluted 100 
fold in an iso‐osmotic Na‐MES buffer, pH 5.5 (~135 mM MES, adjusted to pH 5.5 with NaOH) containing 3.1 µM 
[14C]succinate  in  the  presence  (closed  symbols)  or  absence  (open  circles)  of  0.5  µM  valinomycin.  In  this  way 
chemical  gradients  for  protons  and  sodium  ions were  created.  In  the presence of  valinomycin  an  additional  K+ 
diffusion  potential ΔΨ  (Nernst  potential  ‐118 mV) was  created.  (B)  Initial  [14C]succinate  transport  rates  in  the 
presence of various gradients. Columns correspond to the presence of gradients as follows: 1, all three gradients; 
2, proton gradient and ΔΨ; 3, proton and sodium ion gradient; 4, proton gradient; 5, sodium ion gradient and ΔΨ; 
6,  negative  control.  Initial  transport  rates were  calculated  from  the  15  seconds  timepoints  (see  panel  A). Data 







was  used  as  external  buffer  and  valinomycin  was  present.  ThiT  harbouring  vesicles  were  used  as  a  control  in 
presence of  all  three  gradients. All  data  are  averages of  three  independent measurements;  error  bars  indicate 
standard deviations. 
 
Transport  was  DctA  mediated,  because  no  accumulation  of  succinate  was  observed  in 




rates  and  accumulation  levels  were  strongly  reduced,  regardless  of  the  presence  of  a 
gradient  of  sodium  ions.  An  internal  negative membrane  potential  stimulated  succinate 
transport  rates  and  accumulation  levels  both with  and without  a  pH  gradient,  indicating 
that  transport by DctABs was electrogenic, with a net positive charge moving  in  the same 
direction as the dicarboxylate substrate. 
 
Figure 3: Succinate transport by DctABs  in membrane vesicles  in the presence of putative transport  inhibitors. 
Transport  of  [14C]succinate  (3.1 µM) was measured  in  the  presence  of  all  three  gradients  as  described  in  the 
legend  to  figure 2A. The external buffer was  supplemented with a 50‐fold excess of  the  indicated  compounds. 
Initial transport rates were determined as described in the legend to figure 2B and normalized to the rate without 







excess  of  unlabeled  putative  substrates  inhibited  transport  of  radiolabeled  succinate 
(figure  3).  Only  the  addition  of  the  C4‐dicarboxylates  succinate,  fumarate,  malate  and 
oxaloacetate  strongly  inhibited uptake of  [14C]succinate  into  the membrane vesicles.  The 
addition of maleate and various C3‐ and C5‐dicarboxylates did not inhibit transport. None of 








The  results  of  the  inhibition  assay  (figure  3)  demonstrated  that  DctABs  might  transport 
fumarate, malate  and  oxaloacetate. On  the  other  hand,  these  compounds  could  also  be 
competitive  inhibitors that bind to the transporter without being transported themselves 
and,  thus,  block  transport  of  radiolabeled  succinate.  To  establish  whether  fumarate, 
oxaloacetate and malate were indeed transported by DctABs, we used a counterflow assay. 
Membrane vesicles were loaded with 1 mM of unlabeled (putative) substrate, and diluted 
in  the  same buffer  containing  radiolabeled  succinate.  If  the  unlabeled  dicarboxylate was 
indeed transported, exchange of the  internal  (unlabeled) substrate and external  (labeled) 
succinate  would  lead  to  accumulation  of  the  [14C]succinate,  due  to  the  concentration 





vesicles  did  not  result  in  the  induction  of  succinate  counterflow  by  DctABs,  nor  did  the 
presence  of  aspartate,  glyoxylate  or α‐ketoglutarate  (data  not  shown). We  also  did  not 
observe  succinate  counterflow  when  no  substrate  was  added  to  the  internal  buffer. 
Control  membranes  in  which  ThiT  was  expressed  instead  of  DctABs  also  did  not  show 
counterflow  of  radiolabeled  substrate,  regardless  of  the  presence  of  internal  substrate. 
DctABs  thus appears  specific  for a narrow set of C4‐dicarboxylates. The counterflow assay 
also  showed  that aspartate,  glyoxylate, α‐ketoglutarate, orotate,  citrate and maleate are 








(pH 7.0), supplemented with 1 mM succinate  (closed circles),  fumarate  (open circles), malate  (closed triangles), 
oxaloacetate (open triangles), maleate (open squares), citrate (closed squares) or orotate (closed diamonds), and 
diluted  100  fold  in  external  buffer  (50  mM  potassium  phosphate  pH  7.0)  supplemented  with  3.1  µM 





The  experimental  findings  presented  in  figure  2  indicate  that  DctABs  couples  succinate 
transport to protons, and not to sodium ions. This observation  is  in correspondence with 
results  obtained  for DctA  of C.  glutamicum  in  a whole  cell  experimental  setup  (122).  To 
gain more  insight  into both  the optimal  pH  for  transport  by DctABs,  and  the protonation 
state  of  the  transported  dicarboxylate,  we  measured  the  pH  dependence  of  succinate 
transport  into  membrane  vesicles.  Interpretation  of  the  pH  dependence  of  succinate 
transport  by  DctABs  is  complicated  because  (1)  protons  are  substrates  (co‐transported 
ions),  (2)  the  protonation  state  of  the  dicarboxylate  substrates  depends  on  the  pH;  (3) 





and  found  that  the  transporter  follows Michaelis‐Menten  kinetics,  which  has  also  been 




nmol*(mg  protein)‐1*s‐1)  than  at  pH  5.5  (3.9  nmol*(mg  protein)‐1*s‐1).  This  result  is 
consistent  with  the  protons  being  cosubstrates.  Although  protonation  of  a  pH  sensitive 
regulatory site at the extracellular face of the protein could also explain the results, we will 
show  below  that  such  regulation  is  less  likely.  The  apparent  Km  values  for  succinate 
transport were  identical within  the error of measurement  (means ±  standard deviations, 
2.8 ± 1.0 µM at pH 5.5 and 2.6 ± 1.4 µM at pH 7). The pKa values of the two carboxylate 
groups  in  succinate  are  4.2  and  5.6  respectively.  At  pH  5.5  ~60%  of  succinate  is  in  a 
protonated state (single or double), whereas at pH 7 this percentage is only ~4 %. The 15‐
fold  decrease  in  the  concentration  of  protonated  substrate  was  not  reflected  in  the 
apparent  Km  values,  indicating  that  the  doubly  deprotonated  form  of  succinate must  be 
recognized  by  the  transporter.  Similar  interpretations  of  apparent  Km  values  at  different 
pHs have been made to determine the protonation state of  the substrate  in a glutamate 
transporter  in  L.  lactis  (79).  The  concentration  of  divalent  anionic  succinate  is  ~2‐fold 
higher  at  pH  7  than  at  pH  5.5.  The  increase  was  also  not  reflected  in  the  apparent  Km 




the  internal  pH  from  6  to  8,  so  that  a  pH  gradient  of  1  unit  was maintained.  Succinate 
transport  rates  increased by ~3‐fold when  the  internal pH was  raised  from pH 6  to pH 8 
(figure  5).  The  transport  rates  increased  despite  a  reduction  in  the  concentration  of  the 
cosubstrate (protons) on the outside, which as described above, was shown in the previous 
experiment  to  decrease  the  transport  rate  when  the  internal  pH  was  constant.  It  is 
therefore  likely  that  the  release  of  protons  on  the  inside  was  rate  limiting,  with  the 
stimulating  effect  of  a  higher  internal  pH  being  dominant  over  the  inhibitory  effect  of  a 










Figure 5: pH dependence of  succinate  transport. Membrane vesicles were  loaded with a mixture of 50 mM K‐
MES/50 mM K‐HEPES, set to a pH of 6, 7 or 8, and the  loaded vesicles were diluted  in  iso‐osmotic Na‐MES/Na‐
HEPES set to pH of 5, 6 or 7. External buffers contained 3.1 µM [14C]succinate and 0.5 µM valinomycin. 
 
In  the  third  experiment  the  pH  dependence  of  succinate  transport  by  DctABs  during 
counterflow with  identical  pHs  on  both  sides  of  the membrane was measured. Maximal 
succinate counterflow activity was observed at pHs of 6.5 to 7.0  (figure 6). At  lower pHs, 
and at a pH of 7.5, the rate of exchange was significantly lower. These results suggest that 
in  addition  to  the  substrate,  protons  are  exchanged  during  the  counterflow  assay.  The 
observed pH optimum for counterflow activity may thus be a reflection of the stimulation 
of transport rates by a compromise between (i) high proton concentrations on the outside 
and  (ii)  low  concentrations  on  the  inside  during  the  counterflow  reaction.  These  results 
corroborate  the  interpretation  of  the  findings  from  the  succinate  uptake  experiments 
described above, from which we concluded that the measured pH dependence of succinate 
transport  directly  represents  proton  binding  on  the  outside  and  release  on  the  inside. 
Exchange  of  a  coupling  ion  during  counterflow  has  also  been  observed  previously,  e.g., 




















levels  were  the  same  regardless  of  the  external  potassium  ion  concentration  (data  not 
shown), indicating that the potassium ion concentration does not affect transport. Lack of 
potassium  ion  dependence  has  also  been  observed  previously  for  other  prokaryotic 






Figure  7:  Succinate  transport  in  the  presence  of  membrane  potentials  of  different  magnitudes.  Membrane 
vesicles were loaded with 100 mM Na‐HEPES (pH 7.5) supplemented with 10 mM KCl. Membrane vesicles were 
diluted  in  external  buffer  consisting  of  Na‐MES,  pH  5.5,  3.1 µM  [14C]succinate,  supplemented  with  0 mM  KCl 
(closed  circles),  2  mM  KCl  (open  circles),  10  mM  KCl  (closed  triangles)  or  50  mM  KCl  (open  triangles),  in  the 
presence of 0.5 µM valinomycin. The concentration of Na‐MES was adjusted to ensure that the external solution 
was iso‐osmotic with the internal solution. As a control, succinate transport in membrane vesicles in which ThiT 




external  concentration  of  potassium  was  lower  than  the  internal  concentration,  and 
negative K+ diffusion potentials were generated (figure 7). When K+ concentrations on both 
sides of the membrane were equal, the addition of valinomycin also resulted in an increase 
in  transport  rates.  This  result  indicates  that  the  net  positive  charge  was  translocated 
inward across the membrane. In the absence of valinomycin the translocated charge led to 
the  build‐up  of  a  positive  membrane  potential,  thus  impeding  further  transport.  By 








from  10  °C  up  to  40°C.  The  Q10  value  was  approximately  1.6  between  20°C  and  40°C, 
suggesting  that  significant  conformational  changes  take  place  during  transport.  This  is 
consistent  with  results  obtained  previously  for  GltPh  (Q10  of  3.7)  (90),  or  various  other 












Prokaryotic  transporters  of  the  DAACS  family  can  be  subdivided  into  three  separate 
classes,  based  on  substrate  specificity  (102):  glutamate/aspartate  transporters,  neutral 
amino  acid  transporters  and  transporters  for  C4‐dicarboxylates  of  the  Krebs  cycle. 
Glutamate/aspartate  transporters  and  the  serine/threonine  transporter  SstT  have  been 
studied  in  vitro  using  membrane  vesicles  and  purified  proteins  reconstituted  into 
liposomes, but DctA‐type dicarboxylate transporters have been studied in whole cell assays 
only.  
In  this  report  we  describe  the  characterisation  of  DctA  from  B.  subtilis  in  membrane 
vesicles  from  L.  lactis  in  which  DctABs  was  overproduced.  We  observed  DctABs  specific 
succinate transport in these membranes, and a series of inhibition and counterflow assays 




been  reported  to  transport  other  compounds  such  as  orotate,  glyoxylate  and  α‐
ketoglutarate (122, 123). None of these substrates were transported by DctABs.  
We made  a  homology model  of  the  substrate‐binding  site  of  DctABs  by  using  the  crystal 
structure of GltPh as a template (data not shown). When the amino acids in GltPh involved in 
substrate binding (9) were compared with the corresponding amino acids in DctABs, only a 
few  differences were  found.  The most  obvious  difference  is  the  replacement  of  Asp394 
from GltPh  by  Ser377  in  DctABs.  In  GltPh  Asp394  interacts with  the α‐amino  group  of  the 
substrate  aspartate,  which  is  not  present  in  the  dicarboxylate  substrates  of  DctABs.  The 
binding  pocket  in  GltPh  for  the  two  carboxylates  of  aspartate  is  strongly  conserved  in 
DctABs.  The  pH  dependence  of  succinate  transport  by  DctABs  suggested  that  the  doubly 
deprotonated  (divalent  anionic)  form  of  succinate  was  recognized  by  the  transporter, 
which  would  be  consistent  with  the  presence  of  a  conserved  binding  site  for  the  two 
carboxylate groups, because the divalent anionic form of aspartate  is also transported by 
GltPh (9, 90). 
Substrate  transport  by  DctABs  was  coupled  to  proton  transport  (symport)  and  was  not 
dependent on sodium  ions. Succinate  transport was  stimulated by a negative membrane 
potential,  indicating  that  transport  was  electrogenic.  Therefore,  at  least  three  protons 
must  be  transported  with  the  divalent  anion  succinate.  This  pattern  is  in  contrast  with 
succinate  transport  by  the  Staphylococcus  aureus  protein  SdcS,  a  sodium  coupled  C4‐
dicarboxylate transporter from the DASS (divalent anion:sodium symporter) family, which 
has been characterised using proteoliposomes containing purified protein. SdcS transports 
a  doubly  deprotonated  substrate  together  with  two  sodium  ions,  resulting  in 
electroneutral  transport  (45). On  the other hand,  transport by eukaryotic homologues of 




binding  by  the  aspartate  transporter  GltPh  for  which  a  crystal  structure  has  been 
determined,  has  been  studied  in  detail.  By  using  thallium  ions  to  replace  sodium  in  the 
crystals  of GltPh,  Boudker et  al  found  two distinct  sodium‐binding  sites  in  the protein,  in 
close  proximity  to  the  aspartate‐binding  site  (9).  We  compared  the  sodium  ion‐binding 
sites in the crystal structure of GltPh with sites in the homology model of DctABs, and found 
surprisingly  few  differences.  In  the  first  site,  the  sodium  ion  is  coordinated  by  three 
backbone  carbonyl  oxygen atoms and a  carboxylate  from Asp405  in GltPh.  This  aspartate 
residue  is  conserved  among  human  homologues  (121)  and  another  acidic  residue 
(glutamate)  is  present  in  the  binding  site  of  the  sodium  coupled  serine/threonine 
transporter  SstT  from  E.  coli.  Proton‐coupled  transporters  such  as  DctA  or  bacterial 





The  homology model  of  DctABs  does  not  allow  us  to  pinpoint  the  locations  of  the  three 
proton binding sites, but based on tertiary structure conservation, it seems likely that the 
proton‐binding sites in DctA are at similar positions as the predicted sodium‐binding sites 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